141 related articles for article (PubMed ID: 16604304)
1. Association study of polymorphisms in glycine transporter with schizophrenia.
Tsai SJ; Cheng CY; Hong CJ; Liao DL; Hou SJ; Yen FC; Liou YJ
J Neural Transm (Vienna); 2006 Oct; 113(10):1545-9. PubMed ID: 16604304
[TBL] [Abstract][Full Text] [Related]
2. Polymorphisms in glycine transporter with schizophrenia.
Tsai SJ; Cheng CY; Hong CJ; Liao DL; Liou YJ
Neuropsychopharmacol Hung; 2006 Mar; 8(1):17-21. PubMed ID: 16841561
[TBL] [Abstract][Full Text] [Related]
3. Association study of polymorphisms in post-synaptic density protein 95 (PSD-95) with schizophrenia.
Tsai SJ; Hong CJ; Cheng CY; Liao DL; Liou YJ
J Neural Transm (Vienna); 2007; 114(4):423-6. PubMed ID: 17093888
[TBL] [Abstract][Full Text] [Related]
4. Association study of polymorphisms in the neutral amino acid transporter genes SLC1A4, SLC1A5 and the glycine transporter genes SLC6A5, SLC6A9 with schizophrenia.
Deng X; Sagata N; Takeuchi N; Tanaka M; Ninomiya H; Iwata N; Ozaki N; Shibata H; Fukumaki Y
BMC Psychiatry; 2008 Jul; 8():58. PubMed ID: 18638388
[TBL] [Abstract][Full Text] [Related]
5. The glycine transporter 1 gene (GLYT1) is associated with methamphetamine-use disorder.
Morita Y; Ujike H; Tanaka Y; Kishimoto M; Okahisa Y; Kotaka T; Harano M; Inada T; Komiyama T; Hori T; Yamada M; Sekine Y; Iwata N; Iyo M; Sora I; Ozaki N; Kuroda S
Am J Med Genet B Neuropsychiatr Genet; 2008 Jan; 147B(1):54-8. PubMed ID: 17582620
[TBL] [Abstract][Full Text] [Related]
6. Association study of polymorphisms in the mitochondrial aspartate/glutamate carrier SLC25A12 (aralar) gene with schizophrenia.
Hong CJ; Liou YJ; Liao DL; Hou SJ; Yen FC; Tsai SJ
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Oct; 31(7):1510-3. PubMed ID: 17693006
[TBL] [Abstract][Full Text] [Related]
7. No association of GRIP1 gene polymorphisms with schizophrenia in Chinese population.
Tsai SJ; Liou YJ; Liao DL; Cheng CY; Hong CJ
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Apr; 31(3):752-5. PubMed ID: 17303296
[TBL] [Abstract][Full Text] [Related]
8. Do damaging variants of SLC6A9, the gene for the glycine transporter 1 (GlyT-1), protect against schizophrenia?
Curtis D
Psychiatr Genet; 2020 Oct; 30(5):150-152. PubMed ID: 32796235
[TBL] [Abstract][Full Text] [Related]
9. Disruption of glycine transporter 1 restricted to forebrain neurons is associated with a procognitive and antipsychotic phenotypic profile.
Yee BK; Balic E; Singer P; Schwerdel C; Grampp T; Gabernet L; Knuesel I; Benke D; Feldon J; Mohler H; Boison D
J Neurosci; 2006 Mar; 26(12):3169-81. PubMed ID: 16554468
[TBL] [Abstract][Full Text] [Related]
10. Expression of D-serine and glycine transporters in the prefrontal cortex and cerebellum in schizophrenia.
Burnet PW; Hutchinson L; von Hesling M; Gilbert EJ; Brandon NJ; Rutter AR; Hutson PH; Harrison PJ
Schizophr Res; 2008 Jul; 102(1-3):283-94. PubMed ID: 18400471
[TBL] [Abstract][Full Text] [Related]
11. No association of alcohol dependence with SLC6A5 and SLC6A9 glycine transporter polymorphisms.
Koller G; Zill P; Fehr C; Pogarell O; Bondy B; Soyka M; Preuss UW
Addict Biol; 2009 Sep; 14(4):506-8. PubMed ID: 19650813
[TBL] [Abstract][Full Text] [Related]
12. Association study of the excitatory amino acid transporter 2 (EAAT2) and glycine transporter 1 (GlyT1) gene polymorphism with schizophrenia in a Polish population.
Merk W; Kucia K; Mędrala T; Kowalczyk M; Owczarek A; Kowalski J
Neuropsychiatr Dis Treat; 2019; 15():989-1000. PubMed ID: 31118638
[No Abstract] [Full Text] [Related]
13. A novel glycine transporter-1 (GlyT1) inhibitor, ASP2535 (4-[3-isopropyl-5-(6-phenyl-3-pyridyl)-4H-1,2,4-triazol-4-yl]-2,1,3-benzoxadiazole), improves cognition in animal models of cognitive impairment in schizophrenia and Alzheimer's disease.
Harada K; Nakato K; Yarimizu J; Yamazaki M; Morita M; Takahashi S; Aota M; Saita K; Doihara H; Sato Y; Yamaji T; Ni K; Matsuoka N
Eur J Pharmacol; 2012 Jun; 685(1-3):59-69. PubMed ID: 22542656
[TBL] [Abstract][Full Text] [Related]
14. Glycine Transporters and Its Coupling with NMDA Receptors.
Zafra F; Ibáñez I; Bartolomé-Martín D; Piniella D; Arribas-Blázquez M; Giménez C
Adv Neurobiol; 2017; 16():55-83. PubMed ID: 28828606
[TBL] [Abstract][Full Text] [Related]
15. Inhibitors of GlyT1 affect glycine transport via discrete binding sites.
Mezler M; Hornberger W; Mueller R; Schmidt M; Amberg W; Braje W; Ochse M; Schoemaker H; Behl B
Mol Pharmacol; 2008 Dec; 74(6):1705-15. PubMed ID: 18815213
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of glycine transporter 1: The yellow brick road to new schizophrenia therapy?
Singer P; Dubroqua S; Yee BK
Curr Pharm Des; 2015; 21(26):3771-87. PubMed ID: 26205290
[TBL] [Abstract][Full Text] [Related]
17. Impact of CHRNA5 polymorphisms on the risk of schizophrenia in the Chinese Han population.
Zhan D; Yao Q; Fu S; Liu X; Zhou J; Chen D; Yu C
Mol Genet Genomic Med; 2019 Sep; 7(9):e869. PubMed ID: 31342675
[TBL] [Abstract][Full Text] [Related]
18. Neurobiology of glycine transporters: From molecules to behavior.
Marques BL; Oliveira-Lima OC; Carvalho GA; de Almeida Chiarelli R; Ribeiro RI; Parreira RC; da Madeira Freitas EM; Resende RR; Klempin F; Ulrich H; Gomez RS; Pinto MCX
Neurosci Biobehav Rev; 2020 Nov; 118():97-110. PubMed ID: 32712279
[TBL] [Abstract][Full Text] [Related]
19. Allosteric modulation of NMDA receptor via elevation of brain glycine and D-serine: the therapeutic potentials for schizophrenia.
Yang CR; Svensson KA
Pharmacol Ther; 2008 Dec; 120(3):317-32. PubMed ID: 18805436
[TBL] [Abstract][Full Text] [Related]
20. Transport mechanism and pharmacology of the human GlyT1.
Wei Y; Li R; Meng Y; Hu T; Zhao J; Gao Y; Bai Q; Li N; Zhao Y
Cell; 2024 Mar; 187(7):1719-1732.e14. PubMed ID: 38513663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
